Paul Edward Kelly, Chief Operating Officer at RELMADA THERAPEUTICS, INC. (RLMD), bought 200,000 shares at $0.43 ($86K) on 2025-05-16, disclosed to the SEC on 2025-05-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| RLMD | SELL | 2022-04-05 | $300K | — | Filing → |
| RLMD | SELL | 2021-03-11 | $357K | — | Filing → |
| RLMD | SELL | 2021-02-26 | $338K | — | Filing → |